羚锐制药股价持平 半年度业绩说明会即将举行

Core Viewpoint - The stock price of Lingrui Pharmaceutical remains stable at 22.83 yuan as of August 15, 2025, with a total market capitalization of 12.947 billion yuan [1] Company Overview - Lingrui Pharmaceutical specializes in the research, development, production, and sales of traditional Chinese medicine, offering various dosage forms including plasters, tablets, and capsules [1] - The company operates in sectors such as traditional Chinese medicine, Henan province, and innovative drugs [1] Market Activity - On the trading day, the company recorded a transaction volume of 158 million yuan and a turnover rate of 1.22% [1] - An upcoming semi-annual performance briefing is scheduled for August 26, 2025, which investors are encouraged to follow [1]